Figure 3From: Spread of anti-malarial drug resistance: Mathematical model with implications for ACT drug policiesDelay in the spread of resistance to SP. The delay in the development of resistance is measured as the proportional increase in time to 50% resistance compared to the continued use of SP as a monotherapy.Back to article page